Stammdaten
Unternehmen
| Name | NewAmsterdam Pharma Co N.V. |
|---|---|
| Ticker | NAMS |
| CIK | 0001936258 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | NewAmsterdam Pharma Co N.V. |
Status
| Zuletzt geprüft | 2026-03-20 22:35:16.33255 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -443,707 | 33.25 | -14,753,257.75 | -1411,2% | |
| 2026-02-26 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -165,408 | 33.63 | -5,562,671.04 | -532,1% | |
| 2026-02-26 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -17,924 | 34.44 | -617,302.56 | -59,0% | |
| 2026-02-25 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -46,517 | 35.11 | -1,633,211.87 | -156,2% | |
| 2026-02-25 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -1,300 | 36.68 | -47,684.00 | -4,6% | |
| 2026-02-25 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -10,436 | 35.96 | -375,278.56 | -35,9% | |
| 2026-02-24 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -3,161 | 36.46 | -115,250.06 | -11,0% | |
| 2026-02-24 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -61,547 | 36.13 | -2,223,693.11 | -212,7% | |
| 2026-01-07 | Davidson Michael H. | Director, Officer, Chief Executive Officer | Open Market Sale | -11,582 | 0.00 | 0.00 | 0,0% | |
| 2025-09-15 | Topper James N | Director | Open Market Purchase | 660 | 23.70 | 15,638.90 | +1,5% | |
| 2025-09-15 | Topper James N | Director | Open Market Purchase | 660 | 23.70 | 15,638.90 | +1,5% | |
| 2025-09-15 | Topper James N | Director | Open Market Purchase | 660 | 23.70 | 15,638.90 | +1,5% | |
| 2025-09-15 | Topper James N | Director | Open Market Purchase | 660 | 23.70 | 15,638.90 | +1,5% | |
| 2025-08-11 | Topper James N | Director | Open Market Purchase | 471 | 23.98 | 11,293.97 | +1,1% | |
| 2025-08-11 | Topper James N | Director | Open Market Purchase | 471 | 23.98 | 11,293.97 | +1,1% | |
| 2025-08-11 | Topper James N | Director | Open Market Purchase | 471 | 23.98 | 11,293.97 | +1,1% | |
| 2025-06-25 | Topper James N | Director | Open Market Purchase | 1,260 | 18.26 | 23,011.63 | +2,2% | |
| 2025-06-25 | Topper James N | Director | Open Market Purchase | 1,260 | 18.26 | 23,011.63 | +2,2% | |
| 2025-06-25 | Topper James N | Director | Open Market Purchase | 1,260 | 18.26 | 23,011.63 | +2,2% | |
| 2025-06-24 | Topper James N | Director | Open Market Purchase | 2,520 | 18.43 | 46,454.44 | +4,4% | |
| 2025-06-24 | Topper James N | Director | Open Market Purchase | 2,520 | 18.43 | 46,454.44 | +4,4% | |
| 2025-06-24 | Topper James N | Director | Open Market Purchase | 2,520 | 18.43 | 46,454.44 | +4,4% | |
| 2025-06-16 | Topper James N | Director | Open Market Purchase | 8,584 | 19.50 | 167,381.13 | +16,0% | |
| 2025-06-16 | Topper James N | Director | Open Market Purchase | 8,584 | 19.50 | 167,381.13 | +16,0% | |
| 2025-06-16 | Topper James N | Director | Open Market Purchase | 8,584 | 19.50 | 167,381.13 | +16,0% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.